Dr. Rothenberg announced his departure from the drugmaker in a Jan. 4 tweet, which was confirmed by Steve Danehy, Pfizer’s director of media relations for global essential pharmaceuticals.
Dr. Rothenberg, an oncologist, worked for Pfizer for 12 years and helped establish it as a key participant in developing cancer treatments.
Aida Habtezion, MD, an associate professor at Stanford (Calif.) University’s department of gastroenterology and hepatology, will take over Dr. Rothenberg’s role, Mr. Danehy said.
“Aida is an extremely accomplished physician-scientist as well as an inspirational leader,” Dr. Rothenberg tweeted. “I have every confidence in her continued success in this new role.”
More articles on pharmacy:
FDA: Not enough data to halve COVID-19 vaccine doses
Pfizer to offer COVID-19 vaccines to trial participants who received placebo
6 reasons COVID-19 vaccine rollout is going slower than expected
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
